Abstract:The epigenetic modification of nucleic acids represents a versatile approach for achieving high-efficient control over gene expression and transcription and could dramatically expand their biosensing and therapeutic applications. Demethylase-involved removal of N6-methyladenine (m6A) represents one of the vital epigenetic reprogramming events, yet its direct intracellular evaluation and as-guided gene regulation are extremely rare. The endonuclease-mimicking deoxyribozyme (DNAzyme) is a catalytically active DNA that enables the site-specific cleavage of the RNA substrate, and several strategies have imparted the magnificent responsiveness to DNAzyme by using chemical and light stimuli. However, the epigenetic regulation of DNAzyme has remained largely unexplored, leaving a significant gap in responsive DNA nanotechnology. Herein, we reported an epigenetically responsive DNAzyme system through the in vitro selection of an exquisite m6A-caged DNAzyme that could be specifically activated by FTO (fat mass and obesity-associated protein) demethylation for precise intracellular imaging-directed gene regulation. Based on a systematic investigation, the active DNAzyme configuration was potently disrupted by the site-specific incorporation of m6A modification and subsequently restored into the intact DNAzyme structure via the tunable FTO-specific removal of m6A-caging groups under a variety of conditions. This orthogonal demethylase-activated DNAzyme amplifier enables the robust and accurate monitoring of FTO and its inhibitors in live cells. Moreover, the simple demethylase-activated DNAzyme facilitates the assembly of an intelligent self-adaptive gene regulation platform for knocking down demethylase with the ultimate apoptosis of tumor cells. As a straightforward and scarless m6A removal strategy, the demethylase-activated DNAzyme system offers a versatile toolbox for programmable gene regulation in synthetic biology.

Construction of a N6-Methyladenosine Demethylation-Switched Deoxyribozyme Circuit for in Vitro and in Situ Detection of FTO Activity

Target-induced Activation of Dual DNAzyme Recycling Amplifications for Sensitive Electrochemical Fat Mass and Obesity-Associated Protein Assay

RNA Demethylation-Driven Functional Supramolecular Structure for Label-Free Detection of M6a Modification Eraser FTO in Human Breast Tissues

Highly Sensitive and Selective Demethylase FTO Detection Using a DNAzyme-mediated CRISPR/Cas12a Signal Cascade Amplification Electrochemiluminescence Biosensor with C-CN/PCNV Heterojunction As Emitter

Demethylase FTO activity analysis based on methyl sensitive enzyme MazF and hybridization chain reaction

Engineering M6a Demethylation-Activated DNAzyme for Visually and Sensitively Sensing Fat Mass and Obesity-Associated Protein

Target-promoted Specific Activation of M6a-Dnazyme for SPEXPAR-amplified and Highly Sensitive Non-Label Electrochemical Assay of FTO Demethylase.

Dephosphorylation Switch DNAzyme-RCA Circuit: A Robust Strategy for the Homogeneous and Reliable Detection of FTO Demethylase

A Demethylation-Switchable Aptamer Design Enables Lag-Free Monitoring of M6a Demethylase FTO with Energy Self-Sufficient and Structurally Integrated Features.

Construction of Multiple DNAzymes Driven by Single Base Elongation and Ligation for Single-Molecule Monitoring of FTO in Cancer Tissues

A Label‐free Deoxyribozyme Sensor for m6A Demethylase Activity Detection

A far red emissive RNA aptamer-fluorophore system for demethylase FTO detection: design and optimization

Identification of Specific N 6 -Methyladenosine RNA Demethylase FTO Inhibitors by Single-Quantum-Dot-Based FRET Nanosensors

An RNA Methylation-Sensitive AIEgen-Aptamer Reporting System for Quantitatively Evaluating M6a Methylase and Demethylase Activities

Electrochemical Detection of FTO with N3-kethoxal Labeling and MazF Cleavage

Identification of Specific N6-Methyladenosine RNA Demethylase FTO Inhibitors by Single-Quantum-Dot-Based FRET Nanosensors.

Construction of a Label-Free Fluorescent Biosensor for Homogeneous Detection of M6a Eraser FTO in Breast Cancer Tissues.

Orthogonal Demethylase-Activated Deoxyribozyme for Intracellular Imaging and Gene Regulation.

Homogeneous Electrochemiluminescence for Highly Sensitive Determination of Demethylase FTO Based on Target-Regulated DNAzyme Cleavage and Host-Guest Interaction

Single-Molecule Counting of FTO in Human Breast Tissues Based on a Rolling Circle Transcription Amplification-Driven Clustered Regularly Interspaced Short Palindromic Repeat─Cas12a.

Demethylation-Driven Ligase Chain Reaction for Simultaneously Sensitive Detection of M6a Demethylase FTO and M1a Demethylase ALKBH3 in Breast Cancer at Single-Molecule Level